scholarly article | Q13442814 |
P50 | author | Marie-José Goumans | Q59390020 |
Hans van Dam | Q64513644 | ||
Peter Ten Dijke | Q87987980 | ||
Gonzalo Sanchez-Duffhues | Q88807823 | ||
P2093 | author name string | Margreet R de Vries | |
Amaya García de Vinuesa | |||
Jan H Lindeman | |||
Vera van de Pol | |||
Marlieke E Geerts | |||
Stef Gt Janson | |||
P2860 | cites work | TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4 | Q24314661 |
Cloning and characterization of a human type II receptor for bone morphogenetic proteins | Q24561622 | ||
Bone morphogenetic protein-9 is a circulating vascular quiescence factor | Q24657942 | ||
Targeting BMP signalling in cardiovascular disease and anaemia | Q26783734 | ||
Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability | Q27313607 | ||
Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter | Q28208212 | ||
Crystal structure of BMP-9 and functional interactions with pro-region and receptors | Q28246829 | ||
Characterization of type I receptors for transforming growth factor-beta and activin | Q28251169 | ||
ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation | Q28265302 | ||
Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery | Q28273375 | ||
BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis | Q28289169 | ||
Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
Non-Smad pathways in TGF-beta signaling | Q29620040 | ||
Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells. | Q30829602 | ||
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions | Q33916802 | ||
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene | Q34142690 | ||
Loss of BMPR2 leads to high bone mass due to increased osteoblast activity | Q35233209 | ||
Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis | Q35474247 | ||
Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity | Q35664202 | ||
Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis | Q35683158 | ||
Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. | Q35832692 | ||
Endothelial-Mesenchymal Transition in Vascular Calcification of Ins2Akita/+ Mice. | Q36218686 | ||
Endothelial-to-mesenchymal transition drives atherosclerosis progression | Q36335841 | ||
Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model | Q36835474 | ||
Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis | Q36921054 | ||
Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. | Q37109228 | ||
Anti-inflammatory and antiatherogenic role of BMP receptor II in endothelial cells | Q37136717 | ||
Inhibition of osteoblastic bone formation by nuclear factor-kappaB. | Q37401772 | ||
TGF-beta and BMPR-II pharmacology--implications for pulmonary vascular diseases | Q37423473 | ||
Challenges and opportunities for cardiovascular disease prevention | Q37835932 | ||
Non-Smad signaling pathways | Q37893980 | ||
Identification of novel regulators associated with early-phase osteoblast differentiation | Q38341701 | ||
BMP signaling in vascular biology and dysfunction | Q38715628 | ||
The immunology of atherosclerosis | Q39230390 | ||
Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts | Q39233221 | ||
LRP8 mediates Wnt/β-catenin signaling and controls osteoblast differentiation | Q39347760 | ||
Microtubule stabilization by bone morphogenetic protein receptor-mediated scaffolding of c-Jun N-terminal kinase promotes dendrite formation | Q39736479 | ||
Bone morphogenetic protein expression in human atherosclerotic lesions. | Q40304303 | ||
DNA damage in transcribed genes induces apoptosis via the JNK pathway and the JNK-phosphatase MKP-1. | Q40393322 | ||
Constitutive JNK activation in NIH 3T3 fibroblasts induces a partially transformed phenotype | Q40728305 | ||
Inhibition of osteoblast differentiation by tumor necrosis factor-alpha | Q40840851 | ||
Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2. | Q41484602 | ||
SLUG is expressed in endothelial cells lacking primary cilia to promote cellular calcification | Q41509428 | ||
Endothelial cells transformed by SV40 T antigen cause Kaposi's sarcomalike tumors in nude mice | Q41661906 | ||
Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting | Q41964822 | ||
Cloned spindle and epithelioid cells from murine Kaposi's sarcoma-like tumors are of endothelial origin | Q42810465 | ||
Endothelial fate mapping in mice with pulmonary hypertension | Q44184750 | ||
Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension. | Q46277870 | ||
Endothelial-to-mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry | Q48096975 | ||
Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. | Q51281265 | ||
Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. | Q52100443 | ||
The JNK1/JNK3 interactome--contributions by the JNK3 unique N-terminus and JNK common docking site residues. | Q54316459 | ||
Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice. | Q55036145 | ||
Endothelial-to-mesenchymal transition in pulmonary hypertension. | Q55068646 | ||
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension | Q55670914 | ||
Characterization of in Vivo Phosphorylation of Activin Type II Receptor | Q57267095 | ||
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques | Q77350558 | ||
The natural history of aortic atherosclerosis: a systematic histopathological evaluation of the peri-renal region | Q82325127 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 3 | |
P921 | main subject | vascular calcification | Q54911504 |
P304 | page(s) | 333-346 | |
P577 | publication date | 2019-01-16 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2 | |
P478 | volume | 247 |
Q91588126 | Endothelial Colony Forming Cells as an Autologous Model to Study Endothelial Dysfunction in Patients with a Bicuspid Aortic Valve |
Q95338257 | Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player |
Q90334233 | Interplay between BMPs and Reactive Oxygen Species in Cell Signaling and Pathology |
Q91730362 | Lethal giant larvae 1 inhibits smooth muscle calcification via high mobility group box 1 |
Q90631576 | Research Models for Studying Vascular Calcification |
Q94479612 | TGF-beta and TNF-alpha cooperatively induce mesenchymal transition of lymphatic endothelial cells via activation of Activin signals |
Q94564513 | TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering |
Search more.